StockWatch
·

ULTRAMARINE & PIGMENTS LTD.-$ Q2 FY27 Results

ULTRAMARQ2 FY27 Results
Filing
Result:Good· Market: Up#Margin expansion#Broad based
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue251.684.9%28.4%
Total Income254.953.8%28.5%
Expenditure216.136.3%25.2%
PBT38.828.4%50.4%
Net Profit29.347.1%51.5%
OPM17.82%1.13pp1.68pp
NPM11.51%1.35pp1.75pp
EPS10.057.1%51.6%
View full financials

Chemicals & Allied Products core segment revenue +29.3% and profit +32.4% YoY with net margin expanding to 11.5% from 9.8%, organic and broad-based rather than one-off, but YoY base is itself a strong Q1 (QoQ PAT -7.1%) and no street estimate exists to call it a standout beat.

Q2 FY-2027 RESULTS · ULTRAMAR

Ultramarine & Pigments Q2 FY27: consolidated PAT up 52% YoY to ₹29.3 Cr as margins expand

PAT +51.55% YoY · revenue +28.36% · margins expanding

05 Nov 2026 · 3 min read
Revenue

₹251.68 Cr

+28.36% YoY

PAT (consolidated)

₹29.34 Cr

+51.55% YoY

Net margin

11.51%

+1.8pp YoY

EPS

₹10.05

Ultramarine & Pigments' consolidated revenue rose 28.4% YoY to ₹251.7 Cr and consolidated PAT rose 51.6% YoY to ₹29.3 Cr for Q2 FY27, with net margin expanding to 11.5% from 9.8% and operating margin to 17.8% from 16.1% a year earlier — profit growing faster than revenue is the YoY signal, not the sequential numbers. Quarter-on-quarter, both revenue (+4.9%) and PAT (-7.1%) show the pace cooling versus Q1 FY27's ₹31.6 Cr PAT and 12.9%/19.0% margins; that QoQ dip reads as normalisation off a strong first quarter rather than deterioration, since YoY margins and profit are still comfortably higher. On costs, the overall expense ratio fell to 85.9% of revenue from 88.1% a year ago even as raw-material cost rose to 63.7% of revenue from 59.0% — employee costs (8.6% of revenue vs 10.4%) and other expenses (9.9% vs 11.9%) fell as a share of sales, pointing to operating leverage. The core Chemicals & Allied Products segment (pigments/surfactants) grew revenue 29.3% YoY and segment profit 32.4% YoY to ₹32.8 Cr; the smaller IT-enabled services segment grew profit 60% YoY to ₹5.67 Cr on 18% revenue growth. Standalone PAT grew a slower 40.7% YoY to ₹28.1 Cr against consolidated's 51.6% — a gap wide enough to flag — reflecting the subsidiary's own profit layering on top of the standalone business.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹251.68 Cr+4.9%+28.4%
Expenses₹216.13 Cr+6.3%+25.2%
PAT₹29.34 Cr-7.12%+51.55%
Net margin11.51%-1.3pp+1.8pp
EPS₹10.05-7.1%+51.6%

No street estimates or formal management guidance are available for this stock: no analyst preview or prior-quarter outlook commentary turned up in search, consistent with its small-cap, thinly-covered profile (~₹1,100 Cr market cap at the last close), and management has issued no outlook on record for this filing. Read against the company's own history instead, the scale stands out: half-year FY27 consolidated PAT of ₹60.9 Cr already equals roughly 75% of all of FY26's ₹80.8 Cr full-year PAT, with no exceptional items in either the current or year-ago quarter to adjust for — a clean, organic step-up rather than one-off driven. The one non-operating thread to watch is ownership: promoter group Thirumalai Chemicals has been steadily cutting its stake (a 5% sale flagged September 3, a further 9.5-lakh-share sale October 5) and on October 23 sought reclassification of its holding from promoter to public category — a structural shift in the shareholding base, unconnected to the operating numbers above but material for anyone tracking the stock.

₹
336.71365.88395.05424.22453.39384.4508-0308-2509-1710-1211-0411-05Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹384.45, down 6% over the past month of trading.

₹ Cr
011.7923.5935.3820.19Q1 FY26rev ₹184 Cr19.36Q2 FY26rev ₹196 Cr27.09Q3 FY26rev ₹196 Cr14.15Q4 FY26rev ₹199 Cr31.59Q1 FY27rev ₹240 Cr29.34Q2 FY27rev ₹252 Cr
Quarterly consolidated PAT, ₹ Crore

For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.

  • W1

    Whether Q3 FY27 resumes sequential growth or Q1's ₹31.6 Cr PAT/12.9% NPM marks a seasonal peak, given Q2's QoQ PAT dip of 7.1%

  • W2

    Outcome of promoter group Thirumalai Chemicals' reclassification request (filed Oct 23, 2026) from promoter to public category, following its stake sales on Sep 3 and Oct 5

  • W3

    Whether H2 FY27 sustains the run-rate implied by H1's ₹60.9 Cr consolidated PAT (75% of full FY26 PAT) given no formal management guidance is on record

Informational and educational content only. Not investment advice.